Presentation at the ESSM 2024

Pelvipharm at the Congress of the ESSM (European Society for Sexual Medicine) in Bari, Italy, 8-10 February, 2024.

 

  • François Giuliano will present one abstract during the podium session entitled “Basic science”:

 

 “LIB-01, a novel promising oral drug under development for the treatment of erectile dysfunction (ED) – a summary of nonclinical studies”.
F. Giuliano, D. Gorny, M. Razanakolona, D. Behr-Roussel, R. Assaly, C. Gauffin

Please come and see us, we will be happy to discuss our results with you and potential applications for you.

Presentation at the SMSNA 2023

Pelvipharm at the 24th Annual Fall Scientific Meeting in San Diego, USA, 16-19 November, 2023.
  • François Giuliano will present one abstract : 

“Overview of nonclinical studies of LIB-01, a novel promising oral drug under development for treatment of erectile dysfunction”.

François Giuliano, Diane Gorny, Mahita Razanakolona, Delphine Behr-Roussel, Rana Assaly, Charlotta Gauffin

Please come and see us, we will be happy to discuss our results with you and potential applications for you.

Presentations at the WCE 2023

Pelvipharm at the 15th World Congress on Endometriosis in EdinburgMay 3rd-6th, 2023.

 

  • Delphine Behr-Roussel  will present :
    ” Effect of estrous cycle stage on establishment of a endometriosis rodent model to evaluate the effect of new therapeutic strategies ”
    R. Assaly, S. Compagnie, L. Allimonnier, M. Bracconi, F. Giuliano, L. Alexandre, D. Behr-Roussel.

 

Please come and see us, we will be happy to discuss our results with you and potential applications for you.

Presentation at the ICS 2023

Presentation at the International Continence Society in TorontoSeptember 27th-29th, 2023.

  • Julien Ratelade from EG427 presented the results of a project performed in collaboration with Pelvipharm:

    ” Intravesical administration of EG110A, a novel nonreplicative Herpes Simplex Virus (HSV-1)-derived vector expressing the light chain of botulinum toxin F, inhibits C-type fibers in an acute intravesical capsaicin rat model ”
    Ratelade J1, Faugeroux J2, Behr-Roussel D2, Epstein A1, Denys P3, Giuliano F3, Haag-Molkenteller C1, Salot S1.
    1. EG427, 2. Pelvipharm, 3. Université Versailles Saint-Quentin/Paris Saclay/Faculty of Medicine, Neuro-uro-andrology R. Poincaré academic hospital/APHP,